Precision medicine in pancreatic cancer: Patient derived organoid pharmacotyping is a predictive biomarker of clinical treatment response.
暂无分享，去创建一个
E. Jaffee | D. Tuveson | W. Burns | elliot k fishman | D. Ryan | D. Ting | A. Kimmelman | Jin He | R. Burkhart | K. Lafaro | A. Szabolcs | T. Seppälä | Lei Zheng | J. Zimmerman | R. Suri | C. Shubert | J. Cameron | T. Hong | G. D. Ivey | H. Zlomke | Ying S Zou | James R Eshlemann | L. Zheng | G. Ivey | Jacquelyn W Zimmerman